nach oben

Erschienen in:

23.07.2024 | Comment

Transparency and reporting characteristics of randomized controlled trials with Chinese herbal medicine formulas interventions

verfasst von: Juan Wang, Dongni Shi, Yaochen Wang, Xuanqi Zhang, Han Li, Xihong Wang, Shufeng Luo, Lihan Hu, Jiashuai Deng, Lin Zhang, Chung Tai Lau, Chung Wah Cheng, Fei Han, Ji Li, Ping Wang, Aiping Lyu, Zhaoxiang Bian, Xuan Zhang

Erschienen in: Frontiers of Medicine | Ausgabe 4/2024

Einloggen, um Zugang zu erhalten

Titel: Transparency and reporting characteristics of randomized controlled trials with Chinese herbal medicine formulas interventions
verfasst von: Juan Wang
Dongni Shi
Yaochen Wang
Xuanqi Zhang
Han Li
Xihong Wang
Shufeng Luo
Lihan Hu
Jiashuai Deng
Lin Zhang
Chung Tai Lau
Chung Wah Cheng
Fei Han
Ji Li
Ping Wang
Aiping Lyu
Zhaoxiang Bian
Xuan Zhang
Publikationsdatum: 23.07.2024
Verlag: Higher Education Press
Erschienen in: Frontiers of Medicine / Ausgabe 4/2024
Print ISSN: 2095-0217
Elektronische ISSN: 2095-0225
DOI: https://doi.org/10.1007/s11684-024-1092-4

Unlocking the potential of bispecific ADCs for targeted cancer therapy

Review

Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer

Research Article

Single-cell RNA-seq reveals the transcriptional program underlying tumor progression and metastasis in neuroblastoma

Research Article

Efficacy of acupuncture in refractory irritable bowel syndrome patients: a randomized controlled trial

Open Access
Research Article

lncRNA Gm20257 alleviates pathological cardiac hypertrophy by modulating the PGC-1α–mitochondrial complex IV axis

Research Article

Echocardiographic Measurements in Normal Chinese Adults (EMINCA) II focusing on left ventricular and left atrial size and function by three-dimensional echocardiography

Research Article

Springer Medizin

Transparency and reporting characteristics of randomized controlled trials with Chinese herbal medicine formulas interventions

Weitere Artikel der Ausgabe 4/2024

Unlocking the potential of bispecific ADCs for targeted cancer therapy

Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer

Single-cell RNA-seq reveals the transcriptional program underlying tumor progression and metastasis in neuroblastoma

Efficacy of acupuncture in refractory irritable bowel syndrome patients: a randomized controlled trial

lncRNA Gm20257 alleviates pathological cardiac hypertrophy by modulating the PGC-1α–mitochondrial complex IV axis

Echocardiographic Measurements in Normal Chinese Adults (EMINCA) II focusing on left ventricular and left atrial size and function by three-dimensional echocardiography

Springer Medizin

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Unlocking the potential of bispecific ADCs for targeted cancer therapy

Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer

Single-cell RNA-seq reveals the transcriptional program underlying tumor progression and metastasis in neuroblastoma

Efficacy of acupuncture in refractory irritable bowel syndrome patients: a randomized controlled trial

lncRNA Gm20257 alleviates pathological cardiac hypertrophy by modulating the PGC-1α–mitochondrial complex IV axis

Echocardiographic Measurements in Normal Chinese Adults (EMINCA) II focusing on left ventricular and left atrial size and function by three-dimensional echocardiography